IPF Resources

Resources for Living with IPF

IPF Carebook (Wescoe Foundation)
Patient Guide to Living with Pulmonary Fibrosis
Educational Materials (Pulmonary Fibrosis Foundation)
What is Idiopathic Fibrosis? (National Institue of Health)
IPF Recently Diagnosed Starter Pack (Action for Pulmonary Fibrosis)
Support for IPF Caregivers (Action for Pulmonary Fibrosis)
Study Overview Infographic
Clinical Trial Education Booklet

Advocacy Groups

PFWarriors.com
PulmonaryFibrosis.org
Wescoe.org

In the News

First-in-class agent targets WISP1 in patients with IPF

Facebook Twitter Instagram

Patient Advocacy Strategies

Eligibility Questionnaire

"*" indicates required fields

X/Twitter

This field is for validation purposes and should be left unchanged.

Are you over the age of 40 with a confirmed diagnosis of Idiopathic Pulmonary Fibrosis (IPF)?*

Yes

No

Do you currently smoke?*

Yes

No

Have you been hospitalized because of your IPF in the past 6 months?*

Yes

No

Are you using continuous (24 hours/day) supplemental oxygen for your IPF?*

Yes

No

Do you currently have any active cancer (besides non-melanoma skin cancers) or viral infections, such as Hepatitis B, Hepatitis C, or HIV?*

Yes

No

Are you willing to travel to a research site approximately every 4 weeks over the course of up to 32 weeks (the duration of the study)?*

Yes

No

Thank you for your interest in the WISPer trial. Unfortunately, you do not meet the criteria for enrollment in this study. Please know that research is ongoing, and there may be other clinical trials in the future for which you may be eligible. We appreciate your willingness to contribute to medical advancements.

Your responses indicated you may be eligible to participate in the WISPer Trial.
Please enter your contact information below to be contacted about the study.

Name*

First Last

Email*

Phone*

Location*

City State

Consent*

I hereby consent to the collection, use, and disclosure of my personal information, including my sensitive health information, by Mediar and its partners, to further assess my potential participation in the WISPer Trial. I understand my personal information will be collected, used and disclosed in accordance with the Mediar Privacy Policy.

Yes, I consent